TrialAntimicrobial agents and chemotherapy2016

Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.

Anne-Marie Chaftari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.